1. ACMG. (2013a). Incidental findings in clinical genomics: a clarification. Genetics in Medicine, 8, 664–666.
2. ACMG. (2013b). Mission Statement. Retrieved 19 November 2013, from https://www.acmg.net/ACMG/About_ACMG/Mission_Statement/ACMG/About_ACMG/Mission_Statement.aspx?hkey=473005e6-49fb-4604-84fc-31db71a6a368
3. ACMG. (2014). ACMG Updates Recommendation on “Opt Out” for Genome Sequencing Return of Results. Retrieved 1st July 2014, from https://www.acmg.net/docs/Release_ACMGUpdatesRecommendations_final.pdf
4. Andermann, A., Blancquaert, I., Beauchamp, S., & Dery, V. (2008). Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bulletin of the World Health Organization, 4, 317–319.
5. ASCO. (2003). American society of clinical oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 12, 2397–2406.